Posted on: Mon 09-06-2025

In a powerful show of support for individuals and families affected by Sickle Cell Disease (SCD), the Federal Government of Nigeria has reaffirmed its commitment to improving the diagnosis, treatment, and overall management of the condition across the country. Speaking at the 5th Global Sickle Cell Disease Congress in Abuja, the Minister of Health and Social Services, Prof. Muhammad Ali Pate, emphasized that Nigeria is poised to take a leading role in championing the global fight against SCD.

This announcement is not just symbolic—it comes with a tangible roadmap for progress.

Prof. Pate revealed plans to upgrade the Centre of Excellence for Sickle Cell Disease Research and Training (CESRTA) at the University of Abuja into a full-fledged National Centre of Excellence, with a clear mandate to coordinate national research, training, and innovation in SCD care. This move is a welcome step toward strengthening national capacity and building a unified approach to tackling one of the country’s most prevalent genetic conditions.

“The hosting of this global congress in Abuja underscores the urgency to elevate SCD as a critical public health issue—not just in Nigeria, but worldwide,” Prof. Pate said. “Too many lives have been lost or diminished because this disease has not received the attention it deserves. That must change.”

Concrete Steps, National Impact

The Federal Government’s commitment is already taking form in multiple strategic initiatives. These include:

Universal newborn screening for early detection of SCD across all regions in Nigeria.

Establishment of six specialized SCD centres, equipped with essential diagnostic and treatment tools following rigorous baseline assessments.

Development and dissemination of national guidelines for the prevention and management of SCD.

Partnership with a local pharmaceutical company to increase access to Hydroxyurea, a life-saving medication proven to reduce complications and improve quality of life for people living with SCD.

Ongoing capacity-building programs for healthcare workers at the primary healthcare level to ensure early diagnosis and timely intervention.

These efforts demonstrate not only political will but also a growing recognition that SCD is a significant non-communicable disease (NCD) with far-reaching effects on individuals, families, and national development.

Elevating SCD as a Global Health Priority

Prof. Pate also announced Nigeria’s intention to take on a leading role in the global coalition for sickle cell disease, advocating for its recognition as a major NCD that demands international attention and sustained investment.

This marks a pivotal shift in how SCD is approached—not as a localized or neglected disease, but as a global health challenge that calls for collaboration, innovation, and equity in care.

Voices for Progress

Speaking at the Congress, Prof. Obiageli Nnodu, Director of the newly designated National Centre of Excellence and Co-Chair of the Congress, noted that the event successfully brought together over 60 countries, uniting health professionals, researchers, patients, caregivers, policymakers, and advocates under a shared mission.

“This is only the second time the Global Congress is holding in Africa. The momentum we’re witnessing here in Nigeria is powerful—it reflects a collective will to turn the tide on SCD through research, policy, and partnerships,” Prof. Nnodu affirmed.

A Nation Poised for Leadership in SCD Care

As Nigeria advances toward its Sustainable Development Goals (SDGs)—particularly Goals 1 (No Poverty), 3 (Good Health and Well-being), 4 (Quality Education), and 10 (Reduced Inequalities)—the government’s enhanced focus on SCD reflects a broader vision for equitable and responsive healthcare.

The growing investments, infrastructure upgrades, and knowledge-sharing platforms are signs that Nigeria is not only prioritizing SCD care at home, but also emerging as a continental and global leader in shaping the future of SCD diagnosis, treatment, and research.

This supportive stance invites continued momentum from local and international partners alike. With sustained commitment, the nation’s current efforts can pave the way for a future where no child is left behind because of sickle cell disease.

---

---